Interestingly, Belimumab, a monoclonal antibody against BAFF, was recently approved for SLE treatment and is currently undergoing Phase III clinical trial in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. The gene discussed is TNFSF13B; the disease is systemic lupus erythematosus.